Driveline Infection in Left Ventricular Assist Device Patients: Effect of Standardized Protocols, Pathogen Type, and Treatment Strategy
Authors:
- 27 February 2022
- journal article
- research article
- Published by Wolters Kluwer Health in ASAIO Journal
- Vol. 68 (12) , 1450-1458
Abstract
Driveline infection (DLI) is common after left ventricular assist device (LVAD). Limited data exist on DLI prevention and management. We investigated the impact of standardized driveline care initiatives, specific pathogens, and chronic antibiotic suppression (CAS) on DLI outcomes. 591 LVAD patients were retrospectively categorized based on driveline care initiatives implemented at our institution (2009–2019). Era (E)1: nonstandardized care; E2: standardized driveline care protocol; E3: addition of marking driveline exit site; E4: addition of “no shower” policy. 87(15%) patients developed DLI at a median (IQR) of 403(520) days. S. aureus and P. aeruginosa were the most common pathogens. 31 (36%) of DLI patients required incision and drainage (I&D) and 5 (5.7%) device exchange. P. aeruginosa significantly increased risk for initial I&D (HR 2.7, 95% CI, 1.1–6.3) and recurrent I&D or death (HR 4.2, 95% CI, 1.4–12.5). Initial I&D was associated with a significant increased risk of death (HR 2.92 (1.33–6.44); P = 0.008) when compared to patients who did not develop DLI. Implementation of standardized driveline care protocol (E2) was associated with increased 2-year freedom from DLI compared to nonstandardized care (HR 0.36, 95% CI, 0.2–0.6, P < 0.01). Additional preventive strategies (E3&E4) showed no further reduction in DLI rates. 57(65%) DLI patients received CAS, 44% of them required escalation to intravenous antibiotics and/or I&D. Presence of P. aeruginosa DLI markedly increased risk for I&D or death. Conditional survival of patients progressing to I&D is diminished. Standardized driveline care protocol was associated with a significant reduction in DLI, while additional preventive strategies require further testing.Keywords
This publication has 31 references indexed in Scilit:
- Readmission due to driveline infection can be predicted by new score by using serum albumin and body mass index during long-term left ventricular assist device supportJournal of Artificial Organs, 2015
- Heart transplantation outcomes in patients with continuous-flow left ventricular assist device-related complicationsThe Journal of Heart and Lung Transplantation, 2015
- Left ventricular assist device exchange for persistent infection: a case series and review of the literatureTransplant Infectious Disease, 2014
- Clinical Outcomes Associated With Chronic Antimicrobial Suppression Therapy in Patients With Continuous‐Flow Left Ventricular Assist DevicesArtificial Organs, 2014
- Clinical Manifestations and Management of Left Ventricular Assist Device-Associated InfectionsClinical Infectious Diseases, 2013
- Working formulation for the standardization of definitions of infections in patients using ventricular assist devicesThe Journal of Heart and Lung Transplantation, 2011
- Infectious Complications in Patients With Left Ventricular Assist Device: Etiology and Outcomes in the Continuous-Flow EraThe Annals of Thoracic Surgery, 2010
- Pseudomonas aeruginosa: a formidable and ever-present adversaryJournal of Hospital Infection, 2009
- Antibacterial-ResistantPseudomonas aeruginosa: Clinical Impact and Complex Regulation of Chromosomally Encoded Resistance MechanismsClinical Microbiology Reviews, 2009
- Risk Assessment of Pseudomonas aeruginosa in Water2009